Approval of Paxlovid Corona tablets in the European Union

EU drug regulators have announced the approval of Paxlovid corona tablets for high-risk adults.

EU drug regulators yesterday (Thursday) approved the use of Pfizer’s anti-viral pill called Paxlovid to treat Covid-19.

The European Pharmacopoeia Agency said in a statement that Paxlovid tablets are recommended for adults who do not need oxygen and are at risk for severe disease.

Pfizer announced in November that Paxlovid binds to an enzyme to prevent the virus from multiplying, reducing the risk of severe disease and death from coronavirus when combined with low-dose ritonavir and within five days of the onset of symptoms. Reduces to 89%.

Does Everyone Get Omicron?